Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZN | London | GBP | Real-time | |
3LAZ | London | GBP | Real-time | |
3SAZ | London | GBP | Real-time | |
AZNl | BATS Europe | GBP | Delayed | |
AZNs | BATS Europe | SEK | Delayed | |
AZNCF | OTC Markets | USD | Delayed | |
AZN | NASDAQ | USD | Real-time | |
AZNN | BIVA | MXN | Delayed | |
AZNN | Mexico | MXN | Delayed | |
AZN | Stockholm | SEK | Real-time | |
AZNPy | Frankfurt | EUR | Delayed | |
AZNPy | TradeGate | EUR | Delayed | |
AZN | TradeGate | EUR | Delayed | |
AZN | Frankfurt | EUR | Delayed | |
AZN | Xetra | EUR | Delayed | |
AZNm | Buenos Aires | ARS | Delayed | |
A1ZN34 | B3 | BRL | Delayed | |
AZNA | Vienna | EUR | Real-time |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company’s marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Pascal Soriot | 62 | 2012 | CEO & Executive Director |
Rain Henderson | - | - | Member of External Sustainability Advisory Board |
Michel Demare | 67 | 2019 | Independent Chairman |
Jeffrey Pott | - | 2009 | CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board |
Pam P. Cheng | 52 | 2015 | EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board |
Aradhana Sarin | 48 | 2021 | CFO & Executive Director |
Deborah DiSanzo Eldracher | 64 | 2017 | Independent Non-Executive Director |
Marcus Wallenberg | 68 | 1999 | Non-Executive Director |
Sherilyn S. D. McCoy | 65 | 2017 | Independent Non-Executive Director |
Philip Arthur John Broadley | 63 | 2017 | Senior Independent Non-Executive Director |
Nazneen Rahman | 55 | 2017 | Independent Non-Executive Director |
Louise Nicholls | - | - | Member of External Sustainability Advisory Board |
Andreas Rummelt | 68 | 2021 | Independent Non-Executive Director |
Euan A. Ashley | 51 | 2020 | Independent Non-Executive Director |
Diana Layfield | 52 | 2020 | Independent Non-Executive Director |
Pankaj Bhatia | - | - | Member of External Sustainability Advisory Board |
Polly Courtice | 72 | - | Member of External Sustainability Advisory Board |
Anna Olive Magdelene Manz | 51 | 2023 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review